Alembic Gets USFDA Approval for Generic Deep Vein Thrombosis Medication

Aug 13, 2024 16:54

Alembic Pharmaceuticals receives USFDA approval for its generic Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis and pulmonary embolism prophylaxis.

New Delhi, Aug 13 (PTI) Alembic Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market a generic product indicated for prophylaxis of deep vein thrombosis.

The company has received approval from the US Food and Drug Administration (USFDA) to market Dabigatran Etexilate Capsules (110 mg), the drug firm said in a regulatory filing.

Dabigatran Etexilate Capsules are indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery.

The approved product is therapeutically equivalent to Boehringer Ingelheim Pharmaceuticals Inc's Pradaxa Capsules (110 mg).

The company said it now has a cumulative total of 211 ANDA (abbreviated new drug application) approvals from the USFDA.

Shares of the company on Tuesday closed 3.17 per cent down at Rs 1,076 apiece on the BSE.

Source: PTI

MORE NEWS

SBI Yono 2.0 Launched; Hiring 10,000 Staff

SBI launches Yono 2.0 & plans to hire 10,000 staff to help customers migrate to digital...

Ravi Ranjan Appointed SBI MD

Ravi Ranjan appointed Managing Director of State Bank of India (SBI). He succeeds Vinay...

KSH International IPO: Rs 213 Cr from Anchor...

KSH International raises Rs 213 cr from anchor investors ahead of its IPO. IPO opens...

NCDEX Gets Sebi Nod for Mutual Fund Platform

NCDEX receives Sebi approval for mutual fund platform, paving the way for equity...

WhatsApp Data Sharing: NCLAT Clarifies User...

NCLAT mandates user consent for WhatsApp data collection, including advertising. Learn...

Pajson Agro IPO Subscribed 6.59 Times on Day 3

Pajson Agro India''s Rs 74.4-cr SME IPO subscribed 6.59 times on final day. IPO...

Battery Storage Cost Falls: Rs 2.1/Unit, Power Min

Battery energy storage (BESS) cost drops to Rs 2.1/unit from Rs 10.18 in 2022-23....

India Rice Exports to US: No Dumping, Says...

Commerce Secretary clarifies India exports expensive basmati rice to the US, refuting...

360 One Raises Rs 2,300 Cr Realty Fund

360 One Asset raises Rs 2,300 crore real estate fund, deploying majority in projects....

HRS Aluglaze IPO Subscribed 44.90 Times

HRS Aluglaze SME IPO oversubscribed 44.90 times on final day. Details on subscription,...

Alembic Gets USFDA Approval for Generic Deep Vein Thrombosis Medication

You May Like To Read

MORE NEWS